Factor V Antibody and Disseminated Intravascular Coagulation
- 1 August 1978
- journal article
- research article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 89 (2) , 182-185
- https://doi.org/10.7326/0003-4819-89-2-182
Abstract
A factor V inhibitor arose in a 79 yr old man within 1 mo. of an operation for a fractured leg. Absorption studies with solid-phase antibodies to human immunoglobulins [Ig] showed the inhibitory activity to be primarily in the IgG class, but also in the IgA class, of Ig. This is the 1st report of an IgAIg with factor V inhibitory activity. While the inhibitor was present, and at a time when no circulating Factor V activity was detectable, the patient developed septicemia and disseminated intravascular coagulation. The mechanism sustaining disseminated intravascular coagulation despite the absence of circulating factor V activity remains unexplained. The factor V inhibitor disappeared within 5 mo. of its initial detection. Possible origins of factor V inhibitors were discussed.Keywords
This publication has 5 references indexed in Scilit:
- FACTOR-V ACTIVITY OF PLATELETS - EVIDENCE FOR AN ACTIVATED FACTOR-V MOLECULE AND FOR A PLATELET ACTIVATOR1977
- HETEROGENEITY OF FACTOR-VIII ANTIBODIES - FURTHER IMMUNOCHEMICAL AND BIOLOGIC STUDIES1977
- Factor V Inhibitor: Report of a Case, with Comments on a Possible Effect of StreptomycinAnnals of Internal Medicine, 1973
- The Immunologic Character of Acquired Inhibitors of Antihemophilic Globulin (Factor VIII) and the Kinetics of Their Interaction with Factor VIII*Journal of Clinical Investigation, 1967
- HEMOSTASIS IN FACTOR V DEFICIENCYThe Lancet Healthy Longevity, 1964